Back to Search
LEIGH WENNING, MD
MD
Psychiatry Physician
NPI: 1710357264Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
2007-00053(NC)
Research & Publications (20)
Effect of rifampin, a potent inducer of drug-metabolizing enzymes, on the pharmacokinetics of raltegravir.
PMID 19433563·Antimicrob Agents Chemother·2009
3-trial
Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms.
PMID 19279563·Clin Pharmacol Ther·2009
3-trial
Lack of a significant drug interaction between raltegravir and tenofovir.
PMID 18625763·Antimicrob Agents Chemother·2008
2-rct
Effect of tipranavir-ritonavir on pharmacokinetics of raltegravir.
PMID 19398643·Antimicrob Agents Chemother·2009
3-trial
Lack of a clinically important effect of moderate hepatic insufficiency and severe renal insufficiency on raltegravir pharmacokinetics.
PMID 19223645·Antimicrob Agents Chemother·2009
3-trial
A comparison of the pharmacokinetics of two different formulations of extended-release niacin.
PMID 19210135·Curr Med Res Opin·2009
2-rct
Emerging pharmacology: inhibitors of human immunodeficiency virus integration.
PMID 18928385·Annu Rev Pharmacol Toxicol·2009
6-review
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir.
PMID 18838589·Antimicrob Agents Chemother·2008
2-rct
Minimal pharmacokinetic interaction between the human immunodeficiency virus nonnucleoside reverse transcriptase inhibitor etravirine and the integrase inhibitor raltegravir in healthy subjects.
PMID 18838586·Antimicrob Agents Chemother·2008
3-trial
Atazanavir modestly increases plasma levels of raltegravir in healthy subjects.
PMID 18513146·Clin Infect Dis·2008
2-rct
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
PMID 18441333·J Clin Pharmacol·2008
4-observational
Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation.
PMID 18077730·J Clin Pharmacol·2008
2-rct
Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist.
PMID 17882161·Clin Pharmacol Ther·2008
4-observational
Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects.
PMID 17713476·Clin Pharmacol Ther·2008
3-trial
Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
PMID 17717233·Anesth Analg·2007
7-preclinical
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.
PMID 17721395·J Acquir Immune Defic Syndr·2007
4-observational
Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS.
PMID 17644453·J Chromatogr B Analyt Technol Biomed Life Sci·2007
8-other
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
PMID 17591678·Drug Metab Dispos·2007
7-preclinical
Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans.
PMID 17431030·Drug Metab Dispos·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 BILLINGSLEY RD
CHARLOTTE, NC 28211 - Phone
- (704) 358-2700
Quick Facts
- NPI
- 1710357264
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile